Budget impact of capmatinib for adults with metastatic non-small cell lung cancer harboring a MET exon 14 skipping mutation in the United States
Keyword(s):
Keyword(s):
Keyword(s):
2021 ◽
pp. 1-13
Keyword(s):
2020 ◽
Vol 108
(3)
◽
pp. e404-e405
2019 ◽
Vol 105
(1)
◽
pp. E511
◽
Keyword(s):
2016 ◽
Keyword(s):
Keyword(s):
Keyword(s):
2007 ◽
Vol 69
(3)
◽
pp. S503
Keyword(s):